Universal hepatitis B vaccination and antiviral therapy against viral hepatitis have helped minimize hepatocellular carcinoma (HCC) incidence and mortality rates among Taiwan’s young and middle-aged populations, a recent study has found.
Nonalcoholic fatty liver disease (NAFLD) patients with morbid obesity who undergo bariatric surgery are less likely to develop cancer than their peers who did not go through the procedure, as shown in a study.
The increasing use of social media and online reviews has made it easier for patients to comment publicly—on Facebook and Google reviews, for instance—on the care they receive. Positive comments are heartening for any healthcare professional to read.
Golexanolone, a novel, small molecule, GABA-A receptor-modulating steroid antagonist, helps ease cognitive problems in patients with covert hepatic encephalopathy with no alarming safety signals, a recent study has found.
Beverages sweetened with either fructose or sucrose seem to increase hepatic de novo fatty acid (FA) synthesis, a recent study has found. Interestingly, glucose-sweetened drinks do not have such an effect.
A recent European survey has found major discrepancies and gaps in hospital policies and procedures to prevent the direct transmission of hepatitis B virus (HBV) from mother to child, particularly before and after birth.
In obese patients without gallstones, a 6-month treatment course of ursodeoxycholic acid (UDCA) following bariatric surgery may reduce their likelihood of developing symptomatic gallstones, according to findings of the UPGRADE trial from The Netherlands presented at DDW 2021.